首页> 外文会议>International Pharmaceutical Symposium >Preparation and Characterization of Intravenously Injectable Nimodipine Nanosuspension
【24h】

Preparation and Characterization of Intravenously Injectable Nimodipine Nanosuspension

机译:静脉内注射尼莫氏素纳米肺活量的制备与表征

获取原文

摘要

The purpose of this study was to develop an alternative, improved and better tolerated formulation compared with commercial available nimodipine ethanol solution. In this study, nimodipine nanosuspension was prepared by high pressure homogenization (HPH). The effect of the production parameters such as pressure, cycle numbers and crushing principles on the mean particle size, 99% diameter and polydispersity of the nanosuspension was investigated. Characterization of the product was performed by scanning electron microscope (SEM) and differential scanning calorimeter (DSC). The safety of the nimodipine nanosuspension was discussed with special attention to contamination by microparticles and the increasing in saturation solubility Cs. Irritability study in rabbits showed that this formulation provided less local irritation and phlebitis than ethanol product, which represented a promising new drug formulation for intravenous therapy of subarachnoid hemorrhage (SAH)-related vasospasm.
机译:该研究的目的是与商业可用的尼莫普琳乙醇溶液相比,开发替代,改善和更好的耐受性配方。在该研究中,通过高压均质化(HPH)制备尼莫普宁纳米柱。研究了生产参数如压力,循环编号和破碎原理的效果,对平均粒度,99%直径和纳米术的多分散性进行了研究。通过扫描电子显微镜(SEM)和差示扫描量热计(DSC)来进行产品的表征。纳米哥平纳米苏斯永恒的安全性特别注意微粒污染和饱和溶解度Cs的增加。兔子的烦躁性研究表明,该配方提供了不如乙醇产物的局部刺激和斑眼炎,这代表了对蛛网膜下腔(SAH)相关血管痉挛的静脉内疗法的有希望的新药物制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号